AERIASHIELD BY MOSKITOFREE
ANTIVIRAL EFFECT TESTED IN LABORATORY
A product with antiviral, anti-bacterial and anti-mosquito properties, tested in laboratory.
The service of Doctor Michèle Vialette, Head of Service of the Microbiological Safety Unit, responsible for the High Safety Laboratory at the Pasteur Institute in Lille, supervised the tests on the Aeriashield devices.
The Aeriashield Travel device, tested by the Institut Pasteur de Lille, eliminates 99% of human coronaviruses HCoV-229E in 5 minutes under laboratory conditions (95.8% in 10 minutes for the Aeriashield Family) *. The human coronavirus HCoV-229E is a different coronavirus but from the same family as the causative agent of COVID-19, SARS-CoV2. * sealed enclosure of 1.4 m3 without air renewal.
IMPORTANT MESSAGE ABOUT AERIASHIELD BY MOSKITOFREE
Many of you ask us if our Moskitofree mosquito repellent products, which you would have purchased in the past, or which you would see available for sale on other e-commerce platforms, also have the antiviral properties of Aeriashield by Moskitofree.
Aeriashield by Moskitofree, Family and Travel products are effectively similar in design to our traditional mosquito repellants. However, only the latest generation of our products has been tested in collaboration with the Institut Pasteur de Lille for its antiviral effects. We can therefore guarantee the antiviral effectiveness of our products from now on only on our range stamped Aeriashield by Moskitofree on the packaging, with the visible stamp (Validated by the Institut Pasteur de Lille) on the front of our packaging. Aeriashield by Moskitofree will be currently only available on our website moskitofree.com.